Vandetanib Tablets

Vandetanib Tablets

Form: Tablets

Strength: 300 mg

Reference Brands: Caprelsa

Category: Orphan Drugs

Vandetanib tablets, marketed as Caprelsa, are approved in the US by the FDA and in the EU via EMA for treating medullary thyroid carcinoma. Regulatory approval requires a comprehensive dossier, including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports rapid approval, safe patient use, and worldwide availability to improve outcomes in advanced thyroid cancer management globally. Mitul agarwal Riluzole: Forms, Brands, and Strengths in EU and US OpenAI GPT-4o mini Riluzole: Forms, Brands, and Strengths in EU and US Forms: Oral Tablets: The primary form for use in amyotrophic lateral sclerosis (ALS). Brands & Strengths: US: Rilutek: (brand name) Strengths: 50 mg tablets EU: Riluzole: (generic and branded options) Strengths: Similar 50 mg tablets Summary: Riluzole is available as 50 mg oral tablets in both the US and EU, supported for slowing ALS progression. Generic formulations and branded Rilutek ensure broad access, supporting disease management in ALS patients worldwide with regional regulatory compliance.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Galsulfase IV

Strength: 1mg/ml

Form: Lyophilized powder for IV

Reference Brands: Vimizim®(US & EU)

View Details Get Enquiry
Alglucosidase Alfa IV

Strength: 50 mg/vial

Form: Lyophilized powder

Reference Brands: Lumizyme®(US & EU)

View Details Get Enquiry
Nitisinone tablets

Strength: 2 mg and 5 mg

Form: Tablets

Reference Brands: Orfadin®

View Details Get Enquiry
Treprostinil IV or SC

Strength: 2 mg (0.1 mg/mL), 4 mg (0.2 mg/mL), 8 mg (0.4 mg/mL), 20 mg (1 mg/mL), 50 mg (2.5 mg/mL), 100 mg (5 mg/mL), 200 mg (10 mg/mL), or 400 mg (20 mg/mL)

Form: SC or Intravenous (IV)

Reference Brands: Remodulin®(US & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.